why choose us

First received: July 28, 2022

Clinical Trial: Empagliflozin in Pulmonary Arterial Hypertension

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Idiopathic Pulmonary Arterial Hypertension

Study Type: INTERVENTIONAL


Official Title: Feasibility Study of Empagliflozin As Treatment for Idiopathic Pulmonary Arterial Hypertension

Brief Summary: The aim of the study is to determine whether conducting a randomized placebo-controlled clinical trial is feasible, safe for the patient and whether the treatment is well tolerated in patients with idiopathic pulmonary arterial hypertension.

Read more